학술논문
Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping Alterations
Document Type
Article
Author
Source
In JTO Clinical and Research Reports October 2022 3(10)
Subject
Language
ISSN
2666-3643